Creator marketing budgets continued to expand in 2025, but earnings gains did not spread evenly across creators, according to ...

The sense of a stable middle ground is eroding across an industry at a point of contraction, with many displaying mixed ...

Baxter trades at low valuations with 8x forward cash earnings, debt reduction, cost controls, margin expansion, and $50 2027 ...

So this looked at patients with ER-positive, HER2-Positive metastatic breast cancer who had received induction chemotherapy ...

Background Patients with severe aortic stenosis (AS) are at high risk of mortality, regardless of symptom status. Despite ...

Researchers reconstruct the spatial spread of pandemic respiratory viruses across metropolitan areas throughout the United ...

Small-cap stocks are leading the way in 2026 amid easing rates and earnings growth after lagging for a decade. Discover the ...

Bringing a new drug from discovery to market is a grueling marathon that typically requires 10–15 years of research, testing, and regulatory approval. According to recent data, clinical development ...

This important study, which tackles the challenge of analyzing genome integrity and instability in unicellular pathogens by introducing a novel single-cell genomics approach, presents compelling ...

Learn more about whether Rigetti Computing, Inc. or Veeco Instruments Inc. is a better investment based on AAII's A+ Investor ...

Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today provided a business update including preliminary total revenue and net product ...